Envoy Medical (COCH) versus The Competition Financial Review

Envoy Medical (NASDAQ:COCH) is one of 51 public companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Envoy Medical to similar companies based on the strength of its earnings, dividends, analyst recommendations, profitability, institutional ownership, risk and valuation.

Analyst Recommendations

This is a summary of current ratings and price targets for Envoy Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	399	1399	2525	116	2.53

Envoy Medical currently has a consensus target price of $9.00, suggesting a potential upside of 554.55%. As a group, “Surgical appliances & supplies” companies have a potential upside of 41.89%. Given Envoy Medical’s stronger consensus rating and higher possible upside, research analysts plainly believe Envoy Medical is more favorable than its rivals.

Earnings & Valuation

This table compares Envoy Medical and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$225,000.00	-$29.91 million	-0.98
Envoy Medical Competitors	$1.41 billion	$234.66 million	13.57

Envoy Medical’s rivals have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Envoy Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Insider & Institutional Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Envoy Medical has a beta of 2.35, suggesting that its share price is 135% more volatile than the S&P 500. Comparatively, Envoy Medical’s rivals have a beta of 1.27, suggesting that their average share price is 27% more volatile than the S&P 500.

Summary

Envoy Medical rivals beat Envoy Medical on 7 of the 13 factors compared.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.